Research & Development



  霍去病瞅著雲瑯看了半天,嗤的一聲笑了出來,他不覺得雲瑯會成為一個聖人。   張湯點點頭道︰“就這麼說定了,先期交割七千束絲,秋蠶收獲之後我們再交割剩余的一萬束絲。”久草在线新免费观看A片   回軍營,就會路過長門宮,長門宮的山門外邊的樹樁子上綁著一具尸體。日本AV不卡在线观看   丑庸悲哀的發現,人家手里的抹布都比她身上的衣服料子好。   最悲劇的就是太宰,他因此失去了生育能力。不卡的无码高清的av   雲瑯是一個非常有經驗的嬰兒,這有助于他迅速的融入到這個世界中去。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo